Glass Lewis reaffirms opposition to STAAR Surgical sale to Alcon

Go back to Glass Lewis reaffirms opposition to STAAR Surgical sale to Alcon

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon

December 12, 2025 8:40 AM EST

Contends STAARs Process Was Ineffective in Establishing Competitive Auction and Securing Maximum Value for Shareholders

Argues Boards Procedural Credibility Is Remarkably Threadbare

Broadwood Continues to Urge Shareholders to Vote AGAINST Proposed Transaction

NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today announced that Glass, Lewis & Co., LLC (Glass Lewis), a leading independent proxy advisory firm, has reaffirmed its recommendation that shareholders of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA) should vote... More